Načítá se...
Combination Medical Therapy for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
Medical therapy with α-adrenergic receptor blockers and 5-α-reductase inhibitors is currently considered first-line treatment for men with moderate to severe symptoms of benign prostatic hyperplasia (BPH). Given the success that has been realized with monotherapy with each of these agents, interest...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MedReviews, LLC
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1477629/ https://ncbi.nlm.nih.gov/pubmed/16985890 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|